Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 21 to 25 of 25

Publication Record

Connections

Lack of effect of aprepitant on the pharmacokinetics of docetaxel in cancer patients.
Nygren P, Hande K, Petty KJ, Fedgchin M, van Dyck K, Majumdar A, Panebianco D, de Smet M, Ahmed T, Murphy MG, Gottesdiener KM, Cocquyt V, van Belle S
(2005) Cancer Chemother Pharmacol 55: 609-16
MeSH Terms: Administration, Oral, Aged, Antiemetics, Antineoplastic Agents, Phytogenic, Aprepitant, Cross-Over Studies, Docetaxel, Female, Humans, Infusions, Intravenous, Male, Metabolic Clearance Rate, Middle Aged, Morpholines, Nausea, Neoplasms, Taxoids
Added March 20, 2014
0 Communities
1 Members
0 Resources
17 MeSH Terms
Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.
Swisher SG, Maish M, Erasmus JJ, Correa AM, Ajani JA, Bresalier R, Komaki R, Macapinlac H, Munden RF, Putnam JB, Rice D, Smythe WR, Vaporciyan AA, Walsh GL, Wu TT, Roth JA
(2004) Ann Thorac Surg 78: 1152-60; discussion 1152-60
MeSH Terms: Adenocarcinoma, Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Camptothecin, Carboplatin, Carcinoma, Squamous Cell, Chemotherapy, Adjuvant, Cisplatin, Combined Modality Therapy, Docetaxel, Endosonography, Esophageal Neoplasms, Esophagectomy, Female, Fluorodeoxyglucose F18, Fluorouracil, Humans, Irinotecan, Life Tables, Male, Middle Aged, Neoadjuvant Therapy, Neoplasm Staging, Paclitaxel, Positron-Emission Tomography, Preoperative Care, Prognosis, Proportional Hazards Models, Radiopharmaceuticals, Radiotherapy, Adjuvant, Retrospective Studies, Sensitivity and Specificity, Survival Analysis, Taxoids, Tomography, X-Ray Computed, Treatment Outcome
Added March 27, 2014
0 Communities
1 Members
0 Resources
37 MeSH Terms
Phase II study of gemcitabine in combination with docetaxel in patients with advanced pancreatic carcinoma (E1298). A trial of the eastern cooperative oncology group.
Shepard RC, Levy DE, Berlin JD, Stuart K, Harris JE, Aviles V, Thomas JP, Benson AB
(2004) Oncology 66: 303-9
MeSH Terms: Adult, Aged, Antimetabolites, Antineoplastic, Antineoplastic Agents, Phytogenic, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Deoxycytidine, Disease-Free Survival, Docetaxel, Drug Administration Schedule, Female, Humans, Infusions, Intravenous, Male, Middle Aged, Pancreatic Neoplasms, Survival Analysis, Taxoids, Treatment Failure, United States
Added March 20, 2014
0 Communities
1 Members
0 Resources
20 MeSH Terms
Different in vitro metabolism of paclitaxel and docetaxel in humans, rats, pigs, and minipigs.
Vaclavikova R, Soucek P, Svobodova L, Anzenbacher P, Simek P, Guengerich FP, Gut I
(2004) Drug Metab Dispos 32: 666-74
MeSH Terms: Adolescent, Adult, Animals, Antineoplastic Agents, Phytogenic, Cytochrome P-450 Enzyme System, Docetaxel, Enzyme Inhibitors, Flavonoids, Humans, In Vitro Techniques, Isoenzymes, Kinetics, Male, Microsomes, Liver, Paclitaxel, Rats, Rats, Wistar, Species Specificity, Swine, Swine, Miniature, Taxoids, Troleandomycin
Added May 26, 2014
0 Communities
1 Members
0 Resources
22 MeSH Terms
Phase I trial of outpatient weekly docetaxel, carboplatin and concurrent thoracic radiation therapy for stage III unresectable non-small-cell lung cancer: a Vanderbilt cancer center affiliate network (VCCAN) trial.
Choy H, DeVore RF, Hande KR, Porter LL, Rosenblatt PA, Slovis B, Laporte K, Shyr Y, Johnson DH
(2001) Lung Cancer 34: 441-9
MeSH Terms: Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Carboplatin, Carcinoma, Non-Small-Cell Lung, Combined Modality Therapy, Docetaxel, Drug Administration Schedule, Female, Humans, Lung Neoplasms, Male, Middle Aged, Paclitaxel, Taxoids, Treatment Outcome
Added March 5, 2014
0 Communities
1 Members
0 Resources
16 MeSH Terms